Why Co-Diagnostics Stock Jumped Today

Shares of Co-Diagnostics (NASDAQ: CODX) were jumping 17.4% as of 3:09 p.m. EST on Wednesday. The gain came after the company announced that its joint venture, CoSara Diagnostics, received clearance in India to market the Saragene COVID-19 diagnostic test.

Why are investors cheering Co-Diagnostics' announcement so much? It's not every day that a company gets a green light to market a product in the country with the second-largest population in the world. 

Image source: Getty Images.

Continue reading

Source Fool.com